Craft

Panacea Biotec

Stock Price

₹119.1

2024-06-04

Market Capitalization

₹7.5 B

2024-06-04

Revenue

₹4.6 B

FY, 2023

Panacea Biotec Summary

Company Summary

Overview
Panacea Biotec is a company involved in research, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and natural products. Its product portfolio includes prescription products in therapeutic areas such as pain management, diabetes and cardiovascular management, renal disease management, osteoporosis management, anti-tubercular, as well as gastro-intestinal care products and vaccines.
Type
Public
Status
Active
Founded
1994
Website
https://www.panaceabiotec.com/
Cybersecurity rating
Sectors

Table of Contents

Panacea Biotec Financials

Summary Financials

Revenue (Q3, 2024)
₹1.5B
Gross profit (Q3, 2024)
₹888.6M
Net income (Q3, 2024)
(₹22.0M)
Cash (Q2, 2024)
₹1.5B
EBIT (Q3, 2024)
(₹8.0M)
Enterprise value
$6.5B

Footer menu